PDS Biotechnology (Germany) Top Insiders

PDS Biotechnology Management Team Effectiveness

The company has return on total asset (ROA) of (0.2487) % which means that it has lost $0.2487 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.488) %, meaning that it generated substantial loss on money invested by shareholders. PDS Biotechnology's management efficiency ratios could be used to measure how well PDS Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. PDS Biotechnology owns a total of 28.89 Million outstanding shares. PDS Biotechnology holds 14.2 pct. of its outstanding shares held by insiders and 23.77 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as PDS Biotechnology in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of PDS Biotechnology, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

PDS Biotechnology Workforce Comparison

PDS Biotechnology Corp Benchmark Summation

PDS Biotechnology Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as PDS Biotechnology Corp often depends on how effective the management is. PDS Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PDS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PDS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.